Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Aggressive neuroendocrine tumo...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Aggressive neuroendocrine tumor of the ovary with multiple metastases treated with everolimus: A case report

Aggressive neuroendocrine tumor of the ovary with multiple metastases treated with everolimus: A case report

Bibliographic Details
Main Authors: Michiko Kaiho-Sakuma, Masafumi Toyoshima, Mika Watanabe, Asami Toki, Satomi Kameda, Takamichi Minato, Hitoshi Niikura, Nobuo Yaegashi
Format: Article
Language:English
Published: Elsevier 2018-02-01
Series:Gynecologic Oncology Reports
Subjects:
Carcinoid
Everolimus
Multiple metastases
Neuroendocrine tumor
Ovary
Online Access:http://www.sciencedirect.com/science/article/pii/S235257891830002X
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S235257891830002X

Similar Items

  • Low Grade Neuroendocrine Tumors of the Lung
    by: Barbara Melosky
    Published: (2017-06-01)
  • Management of Small Bowel Neuroendocrine Tumors
    by: Vincent Larouche, et al.
    Published: (2019-09-01)
  • Metformin and Everolimus: A Promising Combination for Neuroendocrine Tumors Treatment
    by: Eleonora Vitali, et al.
    Published: (2020-08-01)
  • Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment?
    by: Christoph Wetz, et al.
    Published: (2020-09-01)
  • Experience of use of everolimus and long-acting somatostatin analogues combination in highly differentiated (G1-G2) neuroendocrine tumors
    by: A A Markovich, et al.
    Published: (2015-09-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...